stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / RMD / Revenue

ResMed Inc. Revenue 2009–2025

ResMed Inc. (RMD) annual revenue by fiscal year, computed from SEC filings. Compound growth +11.4%/yr over 16 years.

Fiscal yearRevenueChange (YoY)
FY 2025$5.15B+9.8%
FY 2024$4.69B+10.9%
FY 2023$4.22B+18.0%
FY 2022$3.58B+11.9%
FY 2021$3.20B+8.1%
FY 2020$2.96B+13.4%
FY 2019$2.61B+11.4%
FY 2018$2.34B+13.2%
FY 2017$2.07B+12.4%
FY 2016$1.84B+9.5%
FY 2015$1.68B+8.0%
FY 2014$1.55B+2.7%
FY 2013$1.51B+10.7%
FY 2012$1.37B+10.1%
FY 2011$1.24B+13.8%
FY 2010$1.09B+18.6%
FY 2009$920.74M

Source: ResMed Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for ResMed Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

ResMed Inc. — frequently asked questions

What is ResMed Inc.'s revenue?

ResMed Inc. (RMD) reported revenue of $5.15B for fiscal year 2025, per its SEC filings.

How has ResMed Inc.'s revenue changed over time?

Between fiscal 2009 and 2025, RMD's revenue grew at roughly 11.4% per year (compound annual rate), from $920.74M to $5.15B.

Where does this data come from?

Figures are computed from ResMed Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More RMD financial history

Full RMD fundamentals page → · All 1,500+ companies →